BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23963148)

  • 21. The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: A cohort study.
    Berntsson J; Svensson MC; Leandersson K; Nodin B; Micke P; Larsson AH; Eberhard J; Jirström K
    Int J Cancer; 2017 Oct; 141(8):1654-1666. PubMed ID: 28677162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The distribution of intratumoral macrophages correlates with molecular phenotypes and impacts prognosis in colorectal carcinoma.
    Kim Y; Wen X; Bae JM; Kim JH; Cho NY; Kang GH
    Histopathology; 2018 Oct; 73(4):663-671. PubMed ID: 29906313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution of Regulatory T-Cells and Other Phenotypes of T-Cells in Tumors and Regional Lymph Nodes of Colorectal Cancer Patients.
    Kazama K; Otake J; Satoyoshi T; Shiozawa M; Sugano N; Sato S; Atsumi Y; Kano K; Murakawa M; Maezawa Y; Hashimoto I; Numata M; Oshima T; Yukawa N; Rino Y; Sasada T; Masuda M
    In Vivo; 2020; 34(2):849-856. PubMed ID: 32111794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High frequency of tumor-infiltrating FOXP3(+) regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients.
    Frey DM; Droeser RA; Viehl CT; Zlobec I; Lugli A; Zingg U; Oertli D; Kettelhack C; Terracciano L; Tornillo L
    Int J Cancer; 2010 Jun; 126(11):2635-43. PubMed ID: 19856313
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intratumoral infiltrating lymphocytes correlate with improved survival in colorectal cancer patients: Independent of oncogenetic features.
    Nazemalhosseini-Mojarad E; Mohammadpour S; Torshizi Esafahani A; Gharib E; Larki P; Moradi A; Amin Porhoseingholi M; Asadzade Aghdaei H; Kuppen PJK; Zali MR
    J Cell Physiol; 2019 Apr; 234(4):4768-4777. PubMed ID: 30370522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune Checkpoints in Circulating and Tumor-Infiltrating CD4
    Toor SM; Murshed K; Al-Dhaheri M; Khawar M; Abu Nada M; Elkord E
    Front Immunol; 2019; 10():2936. PubMed ID: 31921188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An improved image analysis method for cell counting lends credibility to the prognostic significance of T cells in colorectal cancer.
    Väyrynen JP; Vornanen JO; Sajanti S; Böhm JP; Tuomisto A; Mäkinen MJ
    Virchows Arch; 2012 May; 460(5):455-65. PubMed ID: 22527018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II-III colorectal cancer.
    Chaput N; Svrcek M; Aupérin A; Locher C; Drusch F; Malka D; Taïeb J; Goéré D; Ducreux M; Boige V
    Br J Cancer; 2013 Aug; 109(4):1013-22. PubMed ID: 23868006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The PD-1 expressing immune phenotype of T cell exhaustion is prominent in the 'immunoreactive' microenvironment of colorectal carcinoma.
    Prall F; Hühns M
    Histopathology; 2017 Sep; 71(3):366-374. PubMed ID: 28383777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical utility of the local inflammatory response in colorectal cancer.
    Richards CH; Roxburgh CS; Powell AG; Foulis AK; Horgan PG; McMillan DC
    Eur J Cancer; 2014 Jan; 50(2):309-19. PubMed ID: 24103145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decrease in intrahepatic CD56+ lymphocytes in gastric and colorectal cancer patients with liver metastases.
    Gulubova M; Manolova I; Kyurkchiev D; Julianov A; Altunkova I
    APMIS; 2009 Dec; 117(12):870-9. PubMed ID: 20078551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis.
    Zhao Y; Ge X; He J; Cheng Y; Wang Z; Wang J; Sun L
    World J Surg Oncol; 2019 May; 17(1):85. PubMed ID: 31118034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Prognostic Importance of CD20
    Edin S; Kaprio T; Hagström J; Larsson P; Mustonen H; Böckelman C; Strigård K; Gunnarsson U; Haglund C; Palmqvist R
    Sci Rep; 2019 Dec; 9(1):19997. PubMed ID: 31882709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study.
    Laghi L; Bianchi P; Miranda E; Balladore E; Pacetti V; Grizzi F; Allavena P; Torri V; Repici A; Santoro A; Mantovani A; Roncalli M; Malesci A
    Lancet Oncol; 2009 Sep; 10(9):877-84. PubMed ID: 19656725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Colorectal Cancer Immune Infiltrates: Significance in Patient Prognosis and Immunotherapeutic Efficacy.
    Guo L; Wang C; Qiu X; Pu X; Chang P
    Front Immunol; 2020; 11():1052. PubMed ID: 32547556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Image analyzer-based assessment of tumor-infiltrating T cell subsets and their prognostic values in colorectal carcinomas.
    Kim Y; Bae JM; Li G; Cho NY; Kang GH
    PLoS One; 2015; 10(4):e0122183. PubMed ID: 25875774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor Infiltrating T Lymphocytes and Apoptosis in Colorectal Cancer.
    Youssef MM; Paish EC; Murray JC; Farag NM; Saleh K; Ellis IO
    Egypt J Immunol; 2015; 22(1):19-28. PubMed ID: 26415369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intratumoural-infiltrating CD4 + and FOXP3 + T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer.
    Kuwahara T; Hazama S; Suzuki N; Yoshida S; Tomochika S; Nakagami Y; Matsui H; Shindo Y; Kanekiyo S; Tokumitsu Y; Iida M; Tsunedomi R; Takeda S; Yoshino S; Okayama N; Suehiro Y; Yamasaki T; Fujita T; Kawakami Y; Ueno T; Nagano H
    Br J Cancer; 2019 Oct; 121(8):659-665. PubMed ID: 31488881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Fractalkine-Receptor Axis Improves Human Colorectal Cancer Prognosis by Limiting Tumor Metastatic Dissemination.
    Erreni M; Siddiqui I; Marelli G; Grizzi F; Bianchi P; Morone D; Marchesi F; Celesti G; Pesce S; Doni A; Rumio C; Roncalli MG; Laghi L; Mantovani A; Allavena P
    J Immunol; 2016 Jan; 196(2):902-14. PubMed ID: 26673138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rise of PD-L1 expression during metastasis of colorectal cancer: Implications for immunotherapy.
    Wang HB; Yao H; Li CS; Liang LX; Zhang Y; Chen YX; Fang JY; Xu J
    J Dig Dis; 2017 Oct; 18(10):574-581. PubMed ID: 28851046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.